Shares of Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO) rose 19.6% during mid-day trading on Wednesday . The stock traded as high as C$0.33 and last traded at C$0.31. Approximately 20,804 shares traded hands during trading, a decline of 16% from the average daily volume of 24,911 shares. The stock had previously closed at C$0.26.
Aptose Biosciences Stock Up 35.3 %
The stock has a market cap of C$6.25 million, a PE ratio of -0.06 and a beta of 1.36. The business has a 50 day moving average of C$0.30 and a 200-day moving average of C$0.46. The company has a current ratio of 0.80, a quick ratio of 5.41 and a debt-to-equity ratio of 670.80.
About Aptose Biosciences
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Read More
- Five stocks we like better than Aptose Biosciences
- What Makes a Stock a Good Dividend Stock?
- Inflation Persists, But So Do Stock Opportunities: Rally On
- The 3 Best Fintech Stocks to Buy Now
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Shopify Confirms Stock Uptrend, New Highs in Sight
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
